Workflow
上海科华生物工程股份有限公司2025年第一季度报告

Core Viewpoint - The company, Shanghai Kehua Bio-engineering Co., Ltd., has released its first quarter report for 2025, ensuring the accuracy and completeness of the financial information presented [11][17]. Financial Data - The first quarter report has not been audited [3][8]. - The company does not require retrospective adjustments or restatements of previous accounting data [4]. - Non-recurring gains and losses include a refund of personal income tax handling fees [4]. Shareholder Information - As of the reporting period, the company holds 13,696,600 shares in its repurchase account, accounting for 2.66% of the total share capital [6]. Board and Supervisory Meetings - The 13th meeting of the 10th Board of Directors was held on April 29, 2025, with all 9 directors present, including 3 independent directors [10]. - The Board approved the first quarter report, confirming it accurately reflects the company's financial status without any misleading statements [11]. - The 9th meeting of the 10th Supervisory Board also confirmed the report's accuracy and completeness [17].